Assisted reproductive technology (ART) is a procedure used to achieve pregnancy. ART is used to avoid the fertility problems while perpetuating genetic connection. World’s first test tube baby was born in Britain on 25 July 1978 by In-vitro fertilization (IVF). Since then, more than one million babies have been born as the result of assisted reproductive technology. It is observed that infertility affects almost 80 million people worldwide. Overall, one in ten couples suffers with primary or secondary infertility, whereas the infertility rates varies from 5.0% to 30.0% worldwide. Human reproductive technologies came into existence due to rise in infertility rate.
Based on the technology, the ART devices market can be segmented as follows:
- In-vitro fertilization (IVF)
- Intracytoplasmic sperm injection (ICSI)
- Gamete intrafallopian transfer (GIFT),
- Zygote intrafallopian transfer (ZIFT)
- Intrauterine insemination (IUI)
According to the Centers for Disease Control and Prevention (CDC), in 2014, there were around 208,604 ART cycles performed at 458 reporting clinics in the United States, in which 57,323 were live births and 70,354 were live born infants. Overall, of the 208,604 ART cycles performed in 2014, 35,406 were banking cycles in which the intent of the ART cycle was to freeze all resulting eggs or embryos for future ART cycles. It is observed that the use of ART is still rare than its potential demand among people, however its use has been reported to be doubled over the past decade. Relatively 1.6% of all infants born every year are conceived using ART, in the United States.
Based on end users, the ART devices market can be segmented as follows:
- Fertility and surgical centers
- Hospitals and research laboratories
Geographically the ART devices market can be segmented as follows:
- North America
- Asia Pacific
- Middle East & Africa
Europe contributed the largest share in the ART devices market owing to high demand, increasing usage of ART devices and rapidly rising geriatric population. North America market is experiencing significant growth rate due to technological advancements and favorable government initiatives. According to Centers for Disease Control and Prevention (CDC), national public health action plan was developed in June 2014 for the prevention management and detection of infertility. The aim of the policy was to improve the efficacy and safety of infertility treatment. As per the data available in the public databases nearly 588,629 ART cycles were reported in the Europe (33 countries) and nearly 151,923 cycles were reported from the United States. Germany, the U.K., Spain, and Italy are the most active countries for ART in Europe. Asia Pacific is expected to be the fastest growing region due to increasing awareness, late family planning, availability of advanced fertility services, and low fertility rate. Countries in the Latin American region is also experiencing considerable growth in ART devices market owing to increasing healthcare infrastructure and growing demand for quality and safety healthcare services by the patient.
Assisted reproductive technology devices market is anticipated to grow further due to increasing number of government support for infertility procedures, rapidly growing infertility cases, rising disposable income, increasing number of smokers, and rise in the obese population. One in six couples globally experience some form of infertility. It was observed that around 5 million babies had been born from IVF and other reproductive technologies worldwide as or 2015. Due to birth defects risk, disposables of embryo, rise in ethical issues towards ART assisted babies and expensive treatment could restrain the global assisted reproductive technology market.
Major players operating in the global assisted reproductive technology devices market includes Parallabs, Cryolab Ltd., Irvine Scientific, European Sperm Bank Cosmos Biomedical Limited, Microm UK Limited, Origio.
The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.
The study is a source of reliable data on:
- Key market segments and sub-segments
- Evolving market trends and dynamics
- Changing supply and demand scenarios
- Quantifying market opportunities through market sizing and market forecasting
- Tracking current trends/opportunities/challenges
- Competitive insights
- Opportunity mapping in terms of technological breakthroughs
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, Luxembourg)
- Eastern Europe (Poland, Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia and New Zealand)
- Middle East and Africa (GCC, Southern Africa, North Africa)
TMR estimates the market size of various sectors using a combination of available data on the number and revenue of companies within each sub-sector and tiers of companies. The basic components used to determine market size and forecast for a specific product area are not only limited to supply-side data, but are also related to demand, industry trends, and the economic outlook. All the above data points are utilized to generate a statistical model targeting the sector marketplace. More than 300 TMR analysts across the world integrate these elements into a framework to determine the subsector market size for a base year and then forecast growth within each market.
TMR regularly interviews technology and business professionals as an ongoing effort to track the latest developments within each sector. These continuous surveys are stratified by company size and industry segment and weighted to reflect the global market place. All data are collected on an ongoing effort through a structured questionnaire rolled over the web or conducted via telephones. This provides the TMR team opportunities to request for detailed question sets, complex skip patterns, and real-time calculations, which assists respondents in answering questions involving numbers and percentages. Respondents, who are interviewed as experts, are screened and qualified based on certain criteria in addition to their decision-making authority and the scope of activity within their organizations.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.